lung cancer
Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer
Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer
Sukanya Charuchandra | Jun 4, 2018
Merck’s Keytruda extended the lives of lung cancer patients by several months and appeared to stop the progression of advanced melanoma.  
New Liquid Biopsy Detects Cancer at Earlier Stages Than Currently Possible
New Liquid Biopsy Detects Cancer at Earlier Stages Than Currently Possible
Jim Daley | Jun 1, 2018
The test can pick up several types of cancer, including pancreatic and ovarian, years before symptoms appear.
Immune Therapy Improves Lung Cancer Patients’ Survival
Immune Therapy Improves Lung Cancer Patients’ Survival
Jim Daley | Apr 17, 2018
Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.
Image of the Day: Morphing Cells
Image of the Day: Morphing Cells
The Scientist Staff | Mar 27, 2018
By removing a single gene, researchers change the developmental fate of tumor cells in mice.  
Liquid Biopsy Test May Help Screen Eight Types of Cancer
Liquid Biopsy Test May Help Screen Eight Types of Cancer
Jim Daley | Jan 22, 2018
The new diagnostic works by identifying cancer-associated proteins and DNA in patient blood.
First CRISPR Clinical Trial Commences
First CRISPR Clinical Trial Commences
Joshua A. Krisch | Nov 15, 2016
Scientists in China aim to treat 10 people with lung cancer with CRISPR-edited cells.
Smoking-Linked Cancer Mutations Mapped
Smoking-Linked Cancer Mutations Mapped
Anna Azvolinsky | Nov 3, 2016
Scientists produce a detailed genomic map of mutations and epigenetic changes associated with smoking tobacco across 17 tumor types. 
CRISPR Therapy to Enter Trials
CRISPR Therapy to Enter Trials
Jef Akst | Jul 25, 2016
Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.
AACR Releases Tobacco Report
AACR Releases Tobacco Report
Jef Akst | Apr 7, 2014
Researchers and regulators reflect on the progress that has been made in preventing tobacco-related disease in the 50 years since the publication of the first U.S. Surgeon General’s report. 
Catalyzing Lung Cancer Research
Catalyzing Lung Cancer Research
Dan Cossins | Mar 1, 2013
March 2013 Scientist to Watch Emily Scott explains her work on a lung enzyme that interacts with nicotine and may serve as a drug target.